G7, G20 & BRICS Leaders: Finalize the WHO Pandemic Agreement’s Pathogen Access & Benefit-Sharing Annex-Save Millions, Stop the Next Pandemic Before It Starts” (Alternative options for emphasis:) “Urgent Call to G7, G20 & BRICS: Seal the WHO Pandemic Deal’s PABS Annex-Equity, Speed & Sovereignty Must Prevail” “The Last Piece of the Pandemic Puzzle: Why G7, G20 & BRICS Leaders Must Finalize the WHO’s Pathogen-Sharing Framework This July” “A Global Warning: G7, G20 & BRICS Must Act Now-Finalize the WHO’s PABS Annex Before the Next Pandemic Strikes

International negotiators are facing a critical deadline to finalize the Pathogen Access and Benefit-Sharing (PABS) annex, a foundational element of the World Health Organization’s (WHO) proposed pandemic treaty. The annex aims to establish a transparent, predictable system for sharing genetic data of emerging pathogens in exchange for guaranteed equitable access to vaccines, diagnostics, and therapeutics. According to the World Health Organization, member states have set an objective to conclude the broader Pandemic Agreement by the next World Health Assembly in 2025, with specific negotiating sessions scheduled throughout mid-2024 to address remaining gaps in the PABS framework.

The Role of the PABS Annex in Global Health Security

The PABS system is intended to resolve the current, fragmented approach to pandemic response, where access to life-saving tools is often determined by market power rather than public health necessity. During the COVID-19 pandemic, the International Monetary Fund estimated that the global economy suffered losses exceeding $13 trillion, a figure driven by supply chain disruptions, business closures, and widespread economic contraction. The proposed annex seeks to formalize a “fair bargain”: countries that rapidly share information about new pathogens would receive a percentage of the resulting medical countermeasures at affordable prices or via donation.

View this post on Instagram about World Health Organization

This approach moves away from the ad-hoc, case-by-case negotiations that characterized the early stages of the COVID-19 vaccine rollout. By establishing clear rules in advance, the WHO envisions a system that allows laboratories and manufacturers to operate at the speed required for outbreak containment. The World Health Organization maintains that this legal certainty is essential for both equity and the operational efficiency of global biosafety networks.

Addressing Sovereignty and Governance Concerns

A primary point of contention in the ongoing negotiations involves the balance between international cooperation and national sovereignty. Some member states have expressed concerns that a binding agreement might limit their ability to manage domestic health policies. However, the current draft of the WHO Pandemic Agreement explicitly addresses these concerns through Article 22, paragraph 2. This provision clarifies that the agreement does not grant the WHO authority to direct national laws, enforce lockdowns, or mandate specific vaccination policies within sovereign nations. Decisions regarding internal public health measures remain the exclusive prerogative of individual governments.

The negotiation process, overseen by the Intergovernmental Negotiating Body (INB), has proved complex due to the varying priorities of G7, G20, and BRICS nations. While there is a broad consensus on the need for better preparedness, the specific mechanics of benefit-sharing—such as defining what constitutes “fair” access for developing nations—remain under debate. According to reports from the May 2024 negotiating sessions, while significant progress was made on technical definitions, the final language regarding governance and equity in the PABS annex requires further political alignment among member states.

The Urgency of Future Pandemic Preparedness

Scientific estimates suggest that the risk of a new pandemic remains high. According to the World Health Organization, factors such as climate change, shifting land use, and the intensification of agriculture are increasing the frequency of zoonotic spillover events, where viruses jump from animals to humans. These environmental changes mean that the geographic areas where pathogens emerge are no longer restricted to traditional “hotspots.”

The current negotiations are set to continue through mid-July 2024. The primary challenge for delegates is to move from technical discussions to a consensus that satisfies both the need for rapid scientific data sharing and the requirements for equitable distribution of medical tools. If the PABS annex is not finalized, the broader Pandemic Agreement cannot enter into force, leaving the international community without a standardized, legally binding framework for the next global health crisis. The next official update from the Intergovernmental Negotiating Body is expected following the conclusion of the upcoming July sessions.